8-K: Cross Country Healthcare Agrees to $437M Acquisition by Knox Lane

Cross Country Healthcare, Inc. announced a definitive agreement to be acquired by Knox Lane in an all-cash transaction valued at $437 million, offering a significant premium to its shareholders.

Summary

• Cross Country Healthcare, Inc. has entered into a definitive agreement to be acquired by Knox Lane, a growth-oriented investment firm.
• The all-cash transaction is valued at $437 million.
• Shareholders will receive $13.25 per share, representing a premium of approximately 31% to the closing price on May 6, 2026, and 45% to the 90-day volume-weighted average trading price.
• Upon completion, Cross Country Healthcare will become a privately held company and cease trading on the Nasdaq stock exchange.
• The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions, including stockholder approval and regulatory approvals.
• Cross Country Healthcare will continue to operate under its current name and brand.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development for shareholders due to the significant premium offered, though the delisting and privatization represent a neutral to slightly negative aspect for public market investors.

Positives

• Shareholders will receive a significant premium of $13.25 per share, representing a 31% increase over the May 6, 2026 closing price and a 45% increase over the 90-day volume-weighted average trading price.
• The acquisition by Knox Lane, a firm with expertise in the healthcare workforce solutions sector, is expected to help Cross Country Healthcare enter its next phase of growth.
• Knox Lane recognizes the value of Cross Country Healthcare's brand, platform, and proprietary technology.
• The transaction provides immediate and significant value to Cross Country Healthcare's stockholders.

Negatives

• Cross Country Healthcare will be delisted from the Nasdaq stock exchange and become a privately held company.
• The transaction is subject to closing conditions, including stockholder approval and regulatory approvals, which introduce uncertainty.

Risks

• The timing to consummate the proposed Merger may be delayed.
• A condition of closing may not be satisfied, or the closing may otherwise not occur.
• Regulatory approvals required for the Merger may not be obtained or may be obtained subject to unanticipated conditions.
• Management time may be diverted to transaction-related issues, potentially disrupting ongoing business operations.
• Announcements related to the Merger could adversely affect the market price of Company Common Shares.
• The Merger and its announcement could negatively impact the Company's ability to retain customers, key personnel, and maintain relationships with suppliers and customers.
• The occurrence of any event, change, or other circumstance could give rise to the termination of the Merger Agreement, potentially requiring the Company to pay a termination fee.
• Competing offers may be made, potentially disrupting the transaction.

Future Outlook

The filing indicates that upon completion of the transaction, Cross Country Healthcare will become a privately held platform company within Knox Lane's portfolio. The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions. The company will continue to operate under the Cross Country Healthcare name and brand.

Management Comments

• "We are excited to be working with Knox Lane, who brings significant and direct expertise in our sector to help Cross Country Healthcare enter its next phase of growth, while delivering significant and immediate value to our stockholders."
• "Knox Lane truly appreciates our iconic brand and the strength of our platform, especially the proprietary technology we've built on four decades of real-world experience. That foundation uniquely positions organizations to design, predict, and optimize labor strategies with market-leading precision."
• "Just as important, Knox Lane recognizes the exceptional team behind it all, delivering best-in-class solutions to our clients and the thousands of professionals we proudly support every day."
• "Cross Country Healthcare is a longstanding leader and innovator in healthcare workforce solutions, with an unparalleled focus on delivering clinical excellence."
• "We are excited to leverage our extensive experience to bring added strategic focus and capabilities to the business to build on its already strong foundation, technology, and customer relationships."

Industry Context

StockSavvy.ai notes that this acquisition aligns with a broader trend of private equity firms investing in the healthcare staffing and workforce solutions sector, seeking to leverage technology and operational expertise to drive growth and efficiency in an industry facing persistent labor shortages.

Legal Proceedings

• Potential litigation related to the merger is mentioned, with the Company controlling the defense and Parent having the right to consult and participate.

Stakeholder Impact

• Shareholders: Will receive $13.25 per share in cash, representing a significant premium.
• Employees: Will continue employment with the company under Knox Lane, with comparable salary, bonus opportunities, and benefits for at least 12 months post-acquisition. Some company plans will be terminated prior to closing.
• Customers: The company will continue to operate under the Cross Country Healthcare name and brand, with potential for enhanced growth and capabilities under new ownership.
• Suppliers: No immediate direct impact mentioned, but potential changes in operational focus or strategy under new ownership could influence future relationships.

Next Steps

• Cross Country Healthcare stockholders to approve the merger agreement.
• Obtain required regulatory approvals.
• Complete the acquisition, expected in the third quarter of 2026.
• Cross Country Healthcare will be delisted from the Nasdaq stock exchange.
• File definitive proxy statement with the SEC.

Key Dates

Recommendation

The offer price represents a significant premium, making it attractive for current shareholders. However, for investors not yet holding the stock, the current market price may already reflect this premium, and the delisting means it will no longer be a publicly traded security, making a 'hold' recommendation appropriate for existing shareholders while suggesting caution for new investors.

Keywords

Merger Agreement, Acquisition, Cross Country Healthcare, Knox Lane, Healthcare Workforce Solutions, Private Equity, SEC Filing, Form 8-K